Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavel Strnad

Showing results (211-220 of 229) with videos related to

Pageof 23
Sort By:
Frontiers in Cell and Developmental Biology|June 22, 2026
Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinomaAmaya Lopez-Pascual, Jasmin Elurbide, Emiliana Valbuena-Goiricelaya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 3, 2025
Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot StudyMaria Arechederra, Emil Bik, Carla Rojo, et al.
JHEP Reports : Innovation in Hepatology|June 19, 2025
Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosisLorenz Balcar, Malin Fromme, Naomi Kappe, et al.
Gastroenterology|July 4, 2024
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)Virginia C Clark, Charlie Strange, Pavel Strnad, et al.
Translational Oncology|November 16, 2018
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer PhenotypeNicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, et al.
The Journal of Pathology|February 15, 2021
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2Deniz Kuscuoglu, Lisa Bewersdorf, Kathrin Wenzel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 13, 2026
Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in HepatoblastomaLuz A Martínez-Pérez, M Ujue Latasa, Iker Uriarte, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Telomerase gene mutations are associated with cirrhosis formationDaniel Hartmann, Ujala Srivastava, Michaela Thaler, et al.
Zeitschrift Fur Gastroenterologie|September 9, 2024
Thomas Berg, Niklas F Aehling, Tony Bruns, et al.
The Lancet. Gastroenterology & Hepatology|June 15, 2024
Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision frameworkRenée Duijzer, Lucas H P Bernts, Anja Geerts, et al.
Pageof 23

Showing results (211-220 of 229) with videos related to

Sort By:
Pageof 23
Frontiers in Cell and Developmental Biology|June 22, 2026
Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinomaAmaya Lopez-Pascual, Jasmin Elurbide, Emiliana Valbuena-Goiricelaya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 3, 2025
Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot StudyMaria Arechederra, Emil Bik, Carla Rojo, et al.
JHEP Reports : Innovation in Hepatology|June 19, 2025
Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosisLorenz Balcar, Malin Fromme, Naomi Kappe, et al.
Gastroenterology|July 4, 2024
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)Virginia C Clark, Charlie Strange, Pavel Strnad, et al.
Translational Oncology|November 16, 2018
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer PhenotypeNicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, et al.
The Journal of Pathology|February 15, 2021
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2Deniz Kuscuoglu, Lisa Bewersdorf, Kathrin Wenzel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 13, 2026
Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in HepatoblastomaLuz A Martínez-Pérez, M Ujue Latasa, Iker Uriarte, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Telomerase gene mutations are associated with cirrhosis formationDaniel Hartmann, Ujala Srivastava, Michaela Thaler, et al.
Zeitschrift Fur Gastroenterologie|September 9, 2024
Thomas Berg, Niklas F Aehling, Tony Bruns, et al.
The Lancet. Gastroenterology & Hepatology|June 15, 2024
Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision frameworkRenée Duijzer, Lucas H P Bernts, Anja Geerts, et al.
Pageof 23